Marsha Anderson, MD

Professor, Pediatrics-Infectious Diseases


FacultyPhoto
Medical School
  • MD, University of Tennessee Health Science Center College of Medicine (1991)
Undergraduate School
  • BS, University of Iowa (IA) (1982)
Internship
  • University of Colorado (Children's Hospital Colorado) Program (1992)
Residency
  • University of Colorado (Children's Hospital Colorado) Program, Chief Resident, Pediatrics (1995)
Fellowships
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Infectious Diseases (1998)
Languages
English
Department
Pediatrics-Infectious Diseases

Professional Titles

  • Associate Program Director, Pediatric Residency Program
  • Director of Mentored Scholarly Activity

Recognitions

  • Member, Academy of Medical Educators (2010)
  • Fellow, Infectious Disease Society of America (2013)
    “Recognizes and honors those who have achieved professional excellence in infectious diseases and related fields”
  • Denver's Top Doctors-Pediatric Infectious Diseases, 5280 Magazine (2023)

Research Interests

Dr. Anderson's academic interests include medical education and Kawasaki Disease.

Publications

  • Dominguez SR, Anderson MS, El-Adawy M, Glodé MP. Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of kawasaki disease. Pediatr Infect Dis J. 2012 Dec;31(12):1217-20. PubMed PMID: 22760536
  • Anderson MS, Glodé MP. Tick Diseases. Contagious Comments, 2012.
  • Eladawy M, Dominguez SR, Anderson MS, Glodé MP. Kawasaki disease and the pediatric gastroenterologist: a diagnostic challenge. J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):297-9. PubMed PMID: 23085893
  • Dominguez SR, Anderson MS. Advances in the treatment of Kawasaki disease. Curr Opin Pediatr. 2013 Feb;25(1):103-9. PubMed PMID: 23283289
  • Messacar K, Cree-Green M, Lovell M, Anderson MS, Dominguez SR. Severe Neuroinvasive West Nile Virus Infection in a Child with Undiagnosed Addison's Disease. IDCases. 2014;1(3):29-31. PubMed PMID: 25133095
  • Burns JC, Herzog L, Fabri O, Tremoulet AH, Rodó X, Uehara R, Burgner D, Bainto E, Pierce D, Tyree M, Cayan D, Kawasaki Disease Global Climate Consortium (Anderson M data contributor and part of Kawasaki Disease Global Climate Consortium). Seasonality of Kawasaki Disease: A Global Perspective. PLoS ONE, 8(9): e74529. Available at http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0074529, 2013.
  • Narayan AP, McPhillips HA, Anderson MS, Gardner L, Larrabee J, Poynter S, Mann KJ, Spector ND. Strengthening the associate program director workforce: needs assessment and recommendations. Acad Pediatr. 2014 Jul-Aug;14(4):332-4. PubMed PMID: 24976345
  • Anderson MS. Kawasaki Disease. Decision Support in Medicine: Pediatrics (digital clinical support system). https://www.decisionsupportinmedicine.com/ April 2013.
  • Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glodé MP. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate with IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?. J Pediatric Infect Dis Soc. 2015 Apr 20. [Epub ahead of print] PubMed PMID: 26407256
  • Turnier JL, Anderson MS, Heizer HR, Jone PN, Glodé MP, Dominguez SR. Concurrent Respiratory Viruses and Kawasaki Disease. Pediatrics. 2015 Sep;136(3):e609-14. PubMed PMID: 26304824
  • Phadke D, Patel SS, Dominguez SR, Heizer H, Anderson MS, Glode MP, Jone PN. Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease. Pediatr Cardiol. 2015 Dec;36(8):1618-23. PubMed PMID: 25991572
  • Zeft AS, Burns JC, Yeung RS, McCrindle BW, Newburger JW, Dominguez SR, Anderson MS, Arrington C, Shulman ST, Yoon J, Tewelde H, Mix C, Pope CA. Kawasaki Disease and Exposure to Fine Particulate Air Pollution. J Pediatr. 2016 Oct;177:179-183.e1. PubMed PMID: 27496266
  • Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glodé MP. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?. J Pediatric Infect Dis Soc. 2016 Sep;5(3):297-302. PubMed PMID: 26407256
  • Aylor M, Cruz M, Narayan AP, Yu C, Lopreiato JO, Mann KJ, Acholonu RG, Turner T, Serwint JR, Sectish T, Anderson MS, Spector N. Optimizing your Mentoring Relationship: A Toolkit for Mentors and Mentees, MedEd portal, 2016.
  • American Board of Pediatrics/Association of Pediatric Program Directors General Pediatrics EPA Curricular Elements Writing Group. https://www.abp.org/entrustable-professional-activities-epas .
  • Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glode MP, Dominguez SR. Infliximab Plus Intravenous Immunoglobulin (IVIG) versus IVIG Alone as Initial Therapy in Children with Kawasaki Disease Presenting with Coronary Artery Lesions: Is Dual Therapy More Effective? Pediatric Infectious Disease Journal Epub ahead of print Feb 2018. PMID 29461447
  • Haftel HM, Swan R, Anderson MS, Caputo GL, Frohna JG, Li ST, Shugerman RP, Trimm F, Vinci RJ, Waggoner-Fountain LA, Bostwick SB. Fostering the Career Development of Future Educational Leaders: The Success of the APPD LEAD Academic Development Program. Journal of Pediatrics, 194:5-6e1, 2018. PMID 29478508
  • Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC, KIDCARE Multicenter Study Group, Anand V, Anderson MS, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekkar C, DeZure C, Didion L, Dominguez SR, El Faghaly R, Erdam G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SK, Sharma K, Simonsen K, Szmuszkoviczs J, Truong D, Wood J, Yeh S. The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A Phase III, Randomized Rrial of Second Intravenous Immunoglobulin versus Infliximab for Resistant Kawasaki Disease. Contemporary Clinical Trials, 79:98-103, 2019. PMID: 30840903.
  • Tremoulet AH, Jain S, Jone P, Best, GM, Duxbury EH, Franco A, Printz B, Dominguez SR, Heizer H, Anderson MS, Glode MP, He F, Padilla R, Shimizu C, Bainto E, Pancheri J, Cohen H, Whitin JC, Burns JC. Phase I/IIa Trial of Atorvastatin in Acute Kawasaki Disease Patients with Coronary Artery Aneurysms. The Journal of Pediatrics, In press.
  • Dominguez SR, Birkholz M, Anderson MS, Heizer H, Jone P, Glodé MP, Todd JK. Demographic, Diagnostic Evaluation, and Treatment Trends in Children with Kawasaki Disease in the United States, 2006-2015. Pediatric Infectious Disease Journal, 38(10): 1010-1014, 2019. PMID: 31365480
  • Kawasaki Disease, Chapter in: Rheumatology Secrets, 4th Ed, Editors: West S, Kofenbach J; Elsevier, Philadelphia, PA, 2019.
  • Hao S, Ling SB, Kanegaye JT, Bainto E, Dominguez SR, Heizer H, Jone PN, Anderson MS, Jaggi P, Baker A, Newburger JW, Ashouri N, McElhinney DB, Burns JC, Cohen HJ, Tremoulet AH. Multi-Center Validation of a Computer-Based Tool for Differentiation of Acute Kawasaki Disease from Clinically Similar Febrile Illnesses. Archives of Disease in Childhood, 0:1-6, 2020, PMID: 32139365
  • Jone PN, Korst A, Karimpour-Fard A, Thomas T, Dominguez SR, Heizer H, Anderson MS, Glode MP, Sucharov CC, Miyamoto SD. Circulating MicroRNAs Differentiate Kawasaki Disease from Infectious Febrile Illnesses in Childhood, Journal of Molecular and Cellular Cardiology,146:12-18, 2020. PMID: 32634388.
  • Philipsborn RP, Sheffield P, White A, Osta, A, Anderson, MS, Bernstein A. Climate Change and the Practice of Pediatrics: Essentials for Resident Education. Academic Medicine, published ahead of print, September 2020, https://journals.lww.com/academicmedicine/Abstract/9000/Climate_Change_and_the_Practice_of_Medicine_.97003.aspx , PMID: PMID: 32910006.
  • Pediatric Milestones Draft (2.0), ACGME. Anderson M in the Pediatric Milestones Work Group. November 2020, published online https://www.acgme.org/Portals/0/PDFs/Milestones/PediatricsMilestones2.0Draft.pdf
  • Pediatric Draft Milestones Supplemental Guide, ACGME, Anderson M in the Pediatric Milestones Work Group, November 2020, published online. https://www.acgme.org/Portals/0/PDFs/PediatricsSupplementalGuideDraft.pdf
  • Cole LD; Osborne, CM; Silveira LG, Rao S, Lockwood, JM, Kunkel, MJ; MacBrayne CE, Heizer HR, Anderson MS; Jone, P; Dominguez SR. PhD Infliximab Plus IVIG Compared to IVIG Alone in Multisystem Inflammatory Syndrome in Children, Pediatrics, published online ahead of print Sept 2021, e2021052702
  • Pediatric Milestones (2.0), ACGME. Anderson M in the Pediatric Milestones Work Group. March 2021, published online https://www.acgme.org/Portals/0/PDFs/Milestones/PediatricsMilestones2.0.pdf
  • Pediatric Milestones Supplemental Guide, ACGME, Anderson M in the Pediatric Milestones Work Group, March 2021, published online. https://www.acgme.org/Portals/0/PDFs/Milestones/PediatricsSupplementalGuide.pdf
  • Cole LD, Anderson MS, Heizer HR, Hite M, Osborne CM, Dominguez SR, Jone P. Fulfillment of Kawasaki Disease Criteria and Associated Outcomes in Multisystem Inflammatory Syndrome in Children (MIS-C). 13th International Kawasaki Disease Symposium, Virtual, October 2021.
  • Thomas SJ, Anderson MS, Adderson EE, Edgar L, Curtis D, Dong SW, Fatemi Y, Hecht SM, James SH, Lehman A, Michelow IC, Perez N, Sattler MM, Myers AL, Martin-Blais R. Pediatric Infectious Diseases Milestones: A Step in the Right Direction to Evaluate Subspecialty Learners. J Pediatric Infect Dis Soc. 2023 Nov 30;12(11):564-571. PubMed PMID: 37813092
  • Pediatric Infectious Diseases Supplemental Guide, ACGME, 2023 https://www.acgme.org/globalassets/pdfs/milestones/pediatricinfectiousdiseasessupplementalguide.pdf
  • Pediatric Infectious Diseases Milestones 2.0, ACGME, 2023, https://www.acgme.org/globalassets/pdfs/milestones/pediatricinfectiousdiseasesmilestones2.0.pdf

Professional Memberships

  • Accreditation Council for Graduate Medical Education (ACGME) Pediatric Infectious Disease Panel for Accreditation Appeals, Member
  • American Academy of Pediatrics, Member
  • Association of Pediatric Program Directors, Member
  • Colorado Chapter Infectious Disease Society of America, Member
  • ID Week Program Committee, Member
  • Pediatric Infectious Disease Society of America (PIDS), Member
  • PIDS Program and Meetings Committee, Member
  • Society of Pediatric Research, Member
  • USMLE Microbiology and Immunology Panel, Member
  • American Board of Pediatrics Infectious Disease Subboard, Member
  • APPD LEAD Council, Chair

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatric Infectious Diseases, Board Certification (1999, 2016)
  • Pediatrics, Board Certification (2009)
Conditions & Treatments
  • Infections
  • Child and Teen Health - Pediatric Diseases and Conditions
  • Child and Teen Health
  • Kawasaki Disease
  • Infections - Bacterial Infections
  • Infections - Fungal Infections
  • Infections - Influenza
  • Infections - Pneumonia
  • Infections - Viral Infections
Clinical Interests
I am interested in Kawasaki's Disease, Toxin-Mediated Disease and Vaccines.